Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19)

NCT04381364 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Covid-19
Pneumonia, Viral
Sars-CoV2

Interventions

DRUG: Ciclesonide Inhalation Aerosol

Sponsor

Ola Blennow, MD, PhD

Collaborators

[object Object]
[object Object]
[object Object]